IntrinsicIntrinsic

Mergers & Acquisitions ·

Jin Medical International Ltd. completed a VIE control acquisition of Beijing Tongsheng Technology Co., Ltd. on July…

ZJYLJin Medical International Ltd.

Jin Medical International Ltd. completed a VIE control acquisition of Beijing Tongsheng Technology Co., Ltd. on July 21, 2026, issuing 64,186,456 Class A Ordinary Shares to the seller and 6,418,646 shares for financial advisory services. The company also reported unaudited first-half fiscal year 2026 results showing total revenue of $8.9 million, a 9.7% decrease from the prior year period, driven by lower sales to its largest Japanese customer and discontinued electric scooter sales due to regulatory qualification issues. Gross margin improved to 26.9% as operating expenses rose to $3.0 million, resulting in a net loss of $0.2 million compared to a net income of $0.01 million previously. The company maintains $9.1 million in cash and $21.0 million in short-term investments while executing a 1-for-20 reverse stock split effective March 16, 2026. Jin Medical International Ltd. operates in the medical equipment industry, designing, manufacturing, and selling wheelchairs and living aids for people with disabilities.

More from Jin Medical International Ltd.

Explore ZJYL